|Articles|June 9, 2004
Four companies receive approval to sell generic ofloxacin
The FDA in May approved an abbreviated new drug application for four companies to manufacture and sell a generic oxfloxacin ophthalmic solution 0.3% for the treatment of bacterial eye infections, including bacterial conjunctivitis and corneal ulcers.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Malar edema: Perspectives from plastic surgery and ophthalmology
2
Seeing the difference: Multimodal imaging for AMD and GA
3
Topical liposomal ozonated oil may be a useful treatment in neurotrophic keratopathy
4
Unmet Needs in Dry Eye Disease
5



































